Russell Investments Group Ltd. raised its stake in Encompass Health Co. (NYSE:EHC – Free Report) by 29.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 379,719 shares of the company’s stock after purchasing an additional 86,286 shares during the quarter. Russell Investments Group Ltd. owned about 0.38% of Encompass Health worth $20,543,000 at the end of the most recent quarter.
Other hedge funds also recently made changes to their positions in the company. US Bancorp DE lifted its holdings in shares of Encompass Health by 66.4% during the 1st quarter. US Bancorp DE now owns 9,336 shares of the company’s stock valued at $664,000 after acquiring an additional 3,725 shares in the last quarter. Cambridge Investment Research Advisors Inc. acquired a new position in shares of Encompass Health during the 1st quarter valued at $318,000. PNC Financial Services Group Inc. lifted its holdings in shares of Encompass Health by 10.5% during the 1st quarter. PNC Financial Services Group Inc. now owns 8,750 shares of the company’s stock valued at $622,000 after acquiring an additional 834 shares in the last quarter. Bank of Montreal Can lifted its holdings in shares of Encompass Health by 1.5% during the 1st quarter. Bank of Montreal Can now owns 11,340 shares of the company’s stock valued at $806,000 after acquiring an additional 173 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in shares of Encompass Health by 10.5% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 36,463 shares of the company’s stock valued at $2,593,000 after acquiring an additional 3,477 shares in the last quarter. Institutional investors and hedge funds own 92.78% of the company’s stock.
Encompass Health Price Performance
EHC opened at $71.81 on Tuesday. The company has a 50-day moving average of $66.81 and a 200-day moving average of $62.06. The company has a market capitalization of $7.20 billion, a P/E ratio of 23.09, a PEG ratio of 1.74 and a beta of 1.05. Encompass Health Co. has a 1-year low of $45.11 and a 1-year high of $71.96. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.26 and a current ratio of 1.26.
Encompass Health Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Monday, October 2nd will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date is Friday, September 29th. Encompass Health’s dividend payout ratio is presently 19.29%.
Analysts Set New Price Targets
Several research firms recently weighed in on EHC. Stephens restated an “overweight” rating and set a $78.00 target price on shares of Encompass Health in a report on Thursday, July 20th. Mizuho lifted their price target on shares of Encompass Health from $74.00 to $77.00 and gave the stock a “buy” rating in a research note on Thursday, August 3rd. Raymond James lifted their price target on shares of Encompass Health from $80.00 to $85.00 and gave the stock a “strong-buy” rating in a research note on Thursday, August 3rd. Royal Bank of Canada lifted their price target on shares of Encompass Health from $70.00 to $83.00 and gave the stock an “outperform” rating in a research note on Tuesday, August 8th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Encompass Health from $70.00 to $73.00 in a research note on Monday, May 1st. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $77.60.
View Our Latest Research Report on EHC
Encompass Health Profile
Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Featured Stories
- Five stocks we like better than Encompass Health
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 Sizzling Dividends That Are Going On Sale
- Airline Stocks: What They Are and How to Invest
- 3 Ways To Trade, Trade Desk Stock Post Earnings
- How to Buy Gold Stock and Invest in Gold
- Inflation, The Fed, and Oil Prices: Interest Rates Are Going Up
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
